Vitrue Health, a London, UK-based provider of a digital musculoskeletal (MSK) health platform for workplaces, raised $4M in funding.
The round, which brought the total amount to $7M, was led by MC Ventures and Hambro Perks, with participation from Simplyhealth Ventures, Crista Galli Ventures, and Chris Bruce.
The company intends to use the funds to further grow the team and advance its expansion across the US and new markets in Europe.
Led by CEO Shane Lowe, Vitrue Health is a technology startup specialising in reducing musculoskeletal pain. Utilising computer vision and biomechanical analysis, the company offers innovative solutions for workplace health assessments that are accurate, holistic and personalised. Its platform aims to reduce musculoskeletal pain in the workplace, aiding employers in fulfilling their regulatory obligations at scale. It is used by brands such as Bupa, the NHS, Hastings Direct and Campari.
Commenting on the news, Shane Lowe said “Musculoskeletal health conditions have been a societal problem across the world for decades, and our data shows that rates of pain have massively increased since the rise of hybrid working. With this new funding, we’ll be able to continue our growth to reduce the financial and health costs for employers and their teams.”
FinSMEs
29/02/2024